BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1707914)

  • 1. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K
    J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice.
    Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K
    J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A.
    Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K
    J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice.
    Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K
    Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    Immunology; 1993 Jan; 78(1):113-21. PubMed ID: 8436396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction.
    Mayumi H; Good RA
    Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens.
    Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K
    Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential mechanisms of cyclophosphamide-induced skin allograft tolerance including the intrathymic clonal deletion followed by late breakdown of the clonal deletion.
    Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
    J Immunol; 1990 Sep; 145(5):1303-10. PubMed ID: 2143514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
    Mayumi H; Good RA
    Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of peripheral hemopoietic chimerism in achieving donor-specific tolerance in adult mice.
    Maeda T; Eto M; Nishimura Y; Nomoto K; Kong YY; Nomoto K
    J Immunol; 1993 Feb; 150(3):753-62. PubMed ID: 8423338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
    Mayumi H; Good RA
    J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.